June 2023

Alameda Healthcare and Roche Sign MoU to Launch the Oncology Patient Support Program at Egypt’s Second Africa Health ExCon Conference

Alameda Healthcare Group (Alameda) has signed an MoU with Roche Diagnostics (Roche) to extend world-class support to oncology patients through an extensive arrangement that will enhance accessibility and elevate patient care levels.

The cooperation between Alameda and Roche, a global leader in pharmaceuticals and diagnostics, showcases the benefit of cultivating strong relationships and unlocking synergies among leading institutions in the healthcare industry. The MoU marks a significant milestone for the Group in introducing and upgrading new diagnostic advancements that further improve the experience journey of their oncology patients and expedite treatment protocols.

The Oncology Patient Support Program, which aims to address the various challenges faced by oncology patients, will now be implemented for the first time in private Egyptian hospitals through Alameda Healthcare Group. With a focus on reducing costs, early detection, and improving patient outcomes, this program marks a significant milestone in private hospitals within the country. The program aims to revolutionize cancer care in Egypt, providing a comprehensive approach to tackle patient outcomes, alleviating the burden of high treatment costs, and shortening the treatment process.

The MoU will also help standardize patient results across all Alameda hospital labs by upgrading SWA instruments, ensuring consistent and reliable diagnoses, reducing the risk of errors and enabling more accurate treatment plans. Additionally, the implementation of professional devices with full connectivity through "Infinity Edge" middleware for point-of-care testing will establish a comprehensive audit trail, meticulously tracking the entire process from warehouse to patient invoicing. This streamlined approach enhances patient safety, expedites the testing process, and contributes to the overall optimization of healthcare services.

The partnership also includes leveraging cutting-edge Artificial Intelligence technology to support radiologists in the oncology patient care program. By harnessing the power of AI, healthcare professionals will have access to enhanced support, leading to earlier detection, more accurate diagnoses, and timely interventions. These advancements underline the commitment to prioritize patient well-being and deliver the best possible care throughout their healthcare journey, ultimately improving patient lives and outcomes.